Moda-flx Hemodialysis System™
DeviceThe Moda-flx Hemodialysis System™ is a portable hemodialysis system
NCT Number: NCT06613568
The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
North America Research Institute, San Dimas, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Moda-flx Hemodialysis System™ is a portable hemodialysis system
Time frame: Up to 10 weeks per period
Standardized weekly (stdKt/V) values as measured once every week during the Professional Care and At Home treatment settings
Time frame: Up to 10 weeks per period
The adverse event (AE) rate: defined as the number of Study Emergent AEs per 100 dialysis treatments occurring in the At Home period of the study, compared with those occurring during the Professional Care period.
Time frame: Up to 10 weeks per period
Compliance with fluid removal goals that are defined as:
Ultrafiltration (net fluid removal), such that the recorded value from the Moda-flx Hemodialysis System™ is within ± 100 mL/h or ± 250 mL (whichever is less) of set point during the treatment, based on the UF prescription.
Time frame: Up to 10 weeks per period
Study Emergent Pre-Specified Adverse Eventss, categorized by study period (Professional Care and At Home) severity, device relationship and procedure relationship. Study-emergent Pre-Specified AEs are those AEs with an onset on or after the date of first treatment during the Run-In Period, which will be comprised of any of the following:
Contact information is provided by the study sponsor or research team.
Diality Inc.
Industry
Prospective, Non-Randomized, Multicenter, Open-Label Study Evaluating the Use of the Moda-flx Hemodialysis System™ Under Professional Care and At Home by Participants With End Stage Kidney Disease (ESKD) Who Are on Stable Dialysis Regimens
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07426380
Chronic Disease, Disease Attributes
Miami Lakes, Florida, United States
View Trial DetailsNCT04160507
Chronic Disease, Disease Attributes
Durham, North Carolina, United States
View Trial DetailsNCT05418816
Arteriovenous Fistula, Arteriovenous Malformations
Asunción, Paraguay
View Trial DetailsNCT05741489
Chronic Disease, Disease Attributes
Atlanta, Georgia, United States
View Trial Details